A new hope for a therapy against retinitis pigmentosa
16 Jun 2022
Retinitis pigmentosa, a degenerative genetic disease of the eye, is characterized by progressive vision loss, usually leading to blindness. In some patients, structural defects in the photoreceptor cells have been observed, but the molecular mechanisms involved are not understood. The group of Virginie Hamel and Paul Guichard, in collaboration with the University of Lausanne (UNIL), has identified the essential role played by a molecular zipper formed by four proteins. The absence of this zipper leads to cell death in retinal cells. This discovery could lead to the development of therapeutic approaches for retinitis pigmentosa.
This article was published in the journal PLOS Biology on June 16, 2022.
Read the UNIGE's press release.